Innoviva (INVA) Gross Margin (2011 - 2026)
Innoviva (INVA) reported Gross Margin of 77.39% for Q1 2026, down 533.0% on a YoY basis from 17.87% in Q1 2025, and up 10.43% quarter-over-quarter from 70.07% in Q3 2025.
Innoviva (INVA) Gross Margin (2011 - 2026) Analysis & Trends
Innoviva has reported Gross Margin for 9 years, with the latest figure at 77.39% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 533.0% year-over-year to 77.39%; the trailing twelve-month figure through Mar 2026 stood at 100.22% (down 412.0% YoY), and the FY2025 full-year result was 74.8%, down 778.0% from the prior year.
- Gross Margin for Q1 2026 stood at 77.39%, up from 70.07% in the prior quarter.
- The five-year high for Gross Margin was 6220.29% in Q1 2024, with the low at 816.22% in Q2 2023.
- Historically, Gross Margin has averaged 475.6% across 5 years, with a median of 82.91% in 2025.
- Annual changes were most pronounced in 2024 — Gross Margin surged 632129 bps — and 2025, when it plunged 613757 bps.
- Innoviva's Gross Margin stood at 100.0% in 2022, then changed by 0 bps to 100.0% in 2023, then decreased by 18 bps to 81.56% in 2024, then decreased by 14 bps to 70.07% in 2025, then rose by 10 bps to 77.39% in 2026.
- The last three Gross Margin figures came in at 77.39% (Q1 2026), 70.07% (Q3 2025), and 82.91% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 79.04% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Innoviva | 1.65 Bn | 1.05 Bn | 75.83 Mn | 77.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.39% |
| Sep 30, 2025 | 70.07% |
| Jun 30, 2025 | 82.91% |
| Mar 31, 2025 | 82.72% |
| Sep 30, 2024 | 81.56% |
| Jun 30, 2024 | 85.07% |
| Mar 31, 2024 | 6,220.29% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | -816.22% |
| Mar 31, 2023 | -101.01% |
| Sep 30, 2022 | 100.00% |
| Jun 30, 2022 | 100.00% |
| Mar 31, 2022 | 100.00% |
| Sep 30, 2021 | 100.00% |
| Mar 31, 2014 | 75.90% |
| Mar 31, 2013 | 100.00% |
| Dec 31, 2011 | 100.00% |
| Sep 30, 2011 | 100.00% |
| Jun 30, 2011 | 81.58% |